Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel asymmetric conversion method boosts yield to over 80 percent for L-2-aminobutyric acid, offering cost-effective pharma intermediate supply.
Patent CN112521482B reveals advanced nesiritide synthesis via solid-liquid combination. Enhances purity and supply chain reliability for API manufacturing.
Patent CN116554134B details a novel benzofuran synthesis route offering high purity and scalable production for EGFR inhibitor pharmaceutical intermediates.
Patent CN110922360B reveals a continuous reactive distillation method for Edaravone, offering superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1179795A reveals enzyme reuse strategy for beta-lactam antibiotics. Supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1216858C details enzymatic synthesis of CNS drug intermediates. Offers high optical purity and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Novel benzyne-mediated synthesis of phthalazine derivatives offers atom economy and mild conditions for pharmaceutical and electronic material manufacturing supply chains.
Novel Aeromonas caviae B18 strain enables high-purity chiral intermediate production with reduced costs and simplified downstream processing for pharma.
Patent CN101343278A details a cost-effective route for hydrogenated pyridine derivatives, offering reliable supply chain solutions and enhanced purity for global pharmaceutical manufacturers.
Novel entecavir intermediate preparation method offers significant cost reduction and scalable manufacturing for global pharmaceutical supply chains ensuring high purity and regulatory compliance.
Patent CN1052977C details a novel aqueous synthesis of Moclobemide, offering significant cost reduction in API manufacturing through simplified purification and scalable solid intermediates.
Novel synthesis route for Olmesartan intermediate improves yield to 81% via streamlined esterification and Grignard reaction.
Patent CN101759625A details a robust synthesis for 2,4-dimethyl-5-formyl-1H-pyrrole-3-carboxylic acid, offering safer conditions and scalable production for global supply chains.
Patent CN118994222B reveals mild Grignard boronation for BNCT agents. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN104789505B reveals enzymatic route for high purity statin intermediates. Offers cost reduction and supply reliability for pharmaceutical manufacturing.
Novel patent CN104418793A enables cost reduction in API manufacturing via efficient route. High-purity Alzheimer's drug intermediate available for commercial scale-up.
Novel synthesis of Aliskiren intermediate via etherification and enzymatic resolution. Reduces steps and cost for API manufacturing significantly.
Novel patent CN109503691A offers chromium-free synthesis for 5α-androstane-3,17-dione ensuring high purity and supply chain stability for steroid manufacturing.
Patent CN102775471B details a hybrid synthesis for Cholecystokinin Octapeptide. This method offers high purity, avoids hazardous HF, and ensures scalable API intermediate production.
Patent CN1220695A details a microbial process for chiral aminoalcohols, offering a scalable alternative to chemical synthesis for carbocyclic nucleosides.